Product image of Miniflam (Diclofenac Sodium) supplied by GNH India

Miniflam

Active Ingredient:
Diclofenac Sodium
Origin:
EU

Miniflam (Diclofenac Sodium)

Diclofenac Sodium, the active ingredient in Miniflam, is a nonsteroidal anti-inflammatory drug (NSAID) presented as a topical formulation for local application. It works by inhibiting cyclooxygenase enzymes, thereby decreasing prostaglandin synthesis, which helps to alleviate pain, swelling, and stiffness in affected tissues.

GNH India supplies Miniflam as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies, and clinics worldwide through regulated distribution channels. The company adheres to stringent quality standards and supports customers with logistics, regulatory support, and reliable supply chain management.

Manufacturer / TM Owner

Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Diclofenac Sodium is used topically to manage pain and inflammation in musculoskeletal and dermatologic conditions.

  • Osteoarthritis (knee): reduces joint pain and improves functional mobility.
  • Acute muscle sprain: alleviates localized pain and swelling.
  • Actinic keratosis: promotes clearance of precancerous skin lesions.

How It Works

  • Diclofenac Sodium inhibits both cyclooxygenase‑1 (COX‑1) and cyclooxygenase‑2 (COX‑2) enzymes, leading to a decrease in the synthesis of prostaglandins and thromboxanes that mediate inflammation, pain, and fever. By reducing these mediators at the site of application, the drug diminishes vascular permeability, edema, and nociceptor sensitization, providing localized anti‑inflammatory and analgesic effects.

Side Effects

Topical diclofenac may cause a range of skin‑related reactions, from mild irritation to rare but serious systemic events.

Common Side Effects

  • Skin irritation: mild burning or stinging at the application site.
  • Itching or pruritus: localized itching without rash.
  • Redness: erythema surrounding the treated area.
  • Dry skin: occasional flaking or dryness.
  • Rash: mild maculopapular eruption.

Serious or Rare Side Effects

  • Allergic reaction: angioedema, swelling of face or throat.
  • Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
  • Systemic toxicity: hepatic or renal impairment with extensive use.
  • Ulceration: rare ulcer formation on treated skin.
  • Cardiovascular events: increased risk of thrombotic events in susceptible individuals.

Precautions & Warnings

When using Miniflam, certain precautions help minimize risks and ensure safe application.

  • Assess skin integrity: avoid use on broken, infected, or inflamed skin.
  • Limit application area: do not exceed the recommended surface area per dose.
  • Avoid occlusion: do not cover the treated area with airtight dressings unless directed.
  • Caution in cardiovascular disease: use under medical supervision if patient has heart disease.
  • Concomitant systemic NSAIDs: limit combined use to reduce gastrointestinal and renal risk.
  • Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Avoid Interactions

Diclofenac sodium can interact with other medicines, affecting safety or efficacy.

Major Interactions (Avoid)

  • Systemic NSAIDs: increased risk of gastrointestinal bleeding and ulceration.
  • Anticoagulants (e.g., warfarin): heightened bleeding tendency.
  • Lithium: potential rise in serum lithium levels leading to toxicity.

Moderate Interactions (Monitor Closely)

  • ACE inhibitors or ARBs: possible reduction in renal function, especially in dehydrated patients.
  • Diuretics: may enhance renal adverse effects when combined with topical NSAIDs.

Frequently Asked Questions

Miniflam is a topical formulation containing diclofenac sodium, an NSAID used to relieve pain and reduce inflammation in conditions such as osteoarthritis of the knee, acute muscle sprains, and actinic keratosis. It is applied directly to the affected skin area as directed by a healthcare professional.

Diclofenac sodium works by inhibiting the cyclooxygenase (COX) enzymes COX‑1 and COX‑2, which are essential for the production of prostaglandins. By reducing prostaglandin synthesis, it decreases inflammation, pain, and swelling at the site where the medication is applied.

The appropriate dose of Miniflam is determined by the prescribing healthcare professional based on the specific indication, the size of the treatment area, and patient factors. Patients should follow the exact instructions provided on the label or by their clinician.

Safety of topical diclofenac during pregnancy or lactation has not been definitively established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Miniflam.

To order Miniflam, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Miniflam contains diclofenac sodium, which is a potent COX inhibitor commonly used in topical NSAID preparations. Compared with other topical NSAIDs such as ibuprofen or ketoprofen gels, diclofenac often provides stronger anti‑inflammatory effects and is approved for a broader range of dermatologic indications, including actinic keratosis.

Miniflam should be stored at ambient temperature, preferably below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight, and extreme heat to maintain its stability and efficacy.

Miniflam is applied topically to clean, dry skin over the affected area. A thin layer is spread gently and rubbed in until absorbed, typically once or twice daily, or as instructed by a healthcare professional. Hands should be washed after application.

Serious risks include severe allergic reactions such as angioedema, rare but life‑threatening skin conditions like Stevens‑Johnson syndrome, systemic toxicity affecting liver or kidneys with extensive use, and increased risk of cardiovascular events in susceptible patients.

Miniflam should not be used by individuals with known hypersensitivity to diclofenac, other NSAIDs, or any excipients in the formulation. It is also contraindicated on broken, infected, or severely inflamed skin, and should be avoided in patients with a history of severe cardiovascular, hepatic, or renal disease unless directed by a physician.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Diclofenac Sodium

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT